Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00938002 · ClinicalTrials.gov registry record
Study to Determine Quicker Methods of Diagnosing Pneumonia Caused by a Breathing Machine in Critically Ill Patients
A clinical trial of Ventilator Acquired Pneumonia, sponsored by Denver Health and Hospital Authority.
- Completed
- Registry status
- 37
- Enrollment target
- 1
- Study location
NCT00938002: Completed study of Ventilator Acquired Pneumonia, sponsored by Denver Health and Hospital Authority.
NCT00938002 is a study of Ventilator Acquired Pneumonia that has completed, run by Denver Health and Hospital Authority. The registered enrollment target is 37 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00938002, a study of Ventilator Acquired Pneumonia, has completed, sponsored by Denver Health and Hospital Authority.
- COMPLETED
- Registry status
- 37 participants
- Enrollment target
- 1
- Study location
Study Summary
Critically ill patients on a breathing machine are at risk of developing a type of pneumonia called Ventilator Acquired Pneumonia (VAP). The purpose of this study is to determine if regular lung rinses sent for microbiological testing can reduce the time to diagnose VAP. The study also plans to test the accuracy and speed of a new technology, using multiplexed automated digital microscopy, to identify the germs causing the VAP.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Acceler8 Pheno
Study Locations (1)
Colorado
- Denver Health Medical Center - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2009-07 |
| Est. Completion | 2019-09-19 |
What the finished NCT00938002 record still lists
NCT00938002 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 37 participants, a relatively small participant target.
The record links to 1 condition, with Ventilator Acquired Pneumonia appearing as the primary indexed condition, and to 1 intervention - of which Acceler8 Pheno is the first listed.
NCT00938002 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT00938002 about?
NCT00938002 is a clinical study titled "Study to Determine Quicker Methods of Diagnosing Pneumonia Caused by a Breathing Machine in Critically Ill Patients". Critically ill patients on a breathing machine are at risk of developing a type of pneumonia called Ventilator Acquired Pneumonia (VAP). The purpose of this study is to determine if regular lung rinses sent for microbiological testing can reduce the time to diagnose VAP. The study also plans to test...
What is the current status of trial NCT00938002?
This trial is currently completed. The enrollment target is 37 participants. The study started on 2009-07. Estimated completion is 2019-09-19.
What conditions does trial NCT00938002 study?
This clinical trial studies the following conditions: Ventilator Acquired Pneumonia.
What interventions are being tested in trial NCT00938002?
The interventions under investigation include: Acceler8 Pheno (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT00938002?
This trial is sponsored by Denver Health and Hospital Authority, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00938002 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ventilator Acquired Pneumonia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia